Načítá se...
Novel Immunotherapeutic Approaches in Head and Neck Cancer
Unresectable recurrent or metastatic head and neck cancer is an incurable disease with survival of approximately 12 months. Head and neck tumors exhibit numerous derangements in the tumor microenvironment that aid in immune evasion and may serve as targets for future therapies. Pembrolizumab is now...
Uloženo v:
| Vydáno v: | J Cancer Metastasis Treat |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357897/ https://ncbi.nlm.nih.gov/pubmed/32661502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/2394-4722.2019.32 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|